A liquid biopsy blood test may improve children’s survival of cancer in Africa
- In a study published in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of Health and Allied Sciences (MUHAS) in Dar es Salaam, Tanzania have shown that a minimally invasive liquid biopsy test can diagnose Burkitt lymphoma rapidly and accurately in sub-Saharan Africa, where delays in traditional testing often prove fatal.
NHS Supply Chain commits to adoption of Value Based Procurement
- NHS Supply Chain (NHSSC), the leading national organisation in England and Wales for supplying medical devices, healthcare products, services and foods to NHS trusts and healthcare organisations, has finally committed to apply a new value based procurement assessment methodology across its procurement activity.
- In a direct message on social media, the organisation made the commitment for the first time, saying it would “ensure our decisions deliver the best outcomes, value and impact for the NHS”.
NHS England: Consultant buy-in for NHS Online
- NHS England has published a survey finding that 60% of NHS consultants are keen to work for the NHS Online when it launches next year.
- The survey found almost half of consultants and specialist doctors would offer at least four hours per week for the new system.
- Syphilis is a preventable and curable infection, yet recent years have seen a marked increase in diagnoses across England. In 2024, more than 13,000 cases were reported, the highest number since the 1940s.
- The UK Health Security Agency (UKHSA) Syphilis Response Plan sets out our organisational response to syphilis to limit adverse health outcomes, reduce the incidence and address inequalities associated with syphilis.
- Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, and A.D.A.M. Innovations (Japanese corporate name Genesis Healthcare Co.), one of Japan’s leading genetic testing companies, have announced an international collaboration to develop and deploy advanced genomic sequencing and medicine applications based on comprehensive, nanopore sequencing in Japan.
- In its initial phase, the collaboration has the potential to establish Oxford Nanopore’s information-rich, real-time sequencing technology across A.D.A.M. Innovations’ advanced genetic testing portfolio, enabling rapid and precise genomic testing across multiple disease areas.
